TWiV 961: Clinical update with Dr. Daniel Griffin

This Week in Virology

In his weekly clinical update Dr. Griffin discusses Mpox (formerly monkeypox) in women: epidemiological features and clinical characteristics of mpox cases in Spain, April to November 2022, triage of patients with Ebola virus disease, SARS-CoV-2 serology and self-reported infection among adults, serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals, sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants, effect of wearing glasses on risk of infection with SARS-CoV-2 in the community, and data-driven identification of post-acute SARS-CoV-2 infection subphenotypes.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Mpox in women: Epidemiological features and clinical characteristics of cases (Eurosurveillance)
• Triage of patients with Ebola virus disease (The Lancet)
• SARS-CoV-2 serology and self-reported infection among adults (CDC)
• Serological markers of SARS-CoV-2 infection (JID)
• Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody (Journal of infection)
• Effect of wearing glasses on risk of infection with SARS-CoV-2 in the community (JAMA)
• Paxlovid patient eligbiliity screening checklist (FDA)
• Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes (Nature)
• Contribute to our MicrobeTV fundraiser at PWB
• Dr. Griffin’s treatment guide (pdf)
• Letters read on TWiV 961
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [e-mail]